# CANOVA (NCT03539744)

> A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03539744
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: AbbVie
- Conditions: Multiple Myeloma
- Interventions: Pomalidomide; Dexamethasone; Venetoclax
- Enrollment: 265
- Primary outcome: Progression-Free Survival (PFS)

## Indexed commentary on CANOVA so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 73
- YouTube: 27
- Podcasts: 17

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=canova-nct03539744

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03539744", "email": "<work email>"}; the inbox owner confirms by the emailed link.